Universe Pharmaceuticals INC Deferred Tax Assets, Operating Loss Carryforwards
Universe Pharmaceuticals INC (UPC) had Deferred Tax Assets, Operating Loss Carryforwards of $2.17 billion as of 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-01-29
- 2025-09-30: Deferred Tax Assets, Operating Loss Carryforwards $2.17B.
- 2024-09-30: Deferred Tax Assets, Operating Loss Carryforwards $2.20B.
- 2023-09-30: Deferred Tax Assets, Operating Loss Carryforwards $599.08K; Deferred Tax Assets, Operating Loss Carryforwards as first filed $590.28K.
- 2022-09-30: Deferred Tax Assets, Operating Loss Carryforwards $1.21M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-09-30 | $2.17B 20-F · filed 2026-01-29 | |
| 2024-09-30 | $2.20B 20-F · filed 2026-01-29 | |
| 2023-09-30 | $599.08K 20-F · filed 2025-04-29 | $590.28K 20-F · filed 2024-01-30 |
| 2022-09-30 | $1.21M 20-F · filed 2024-01-30 | |
| 2022-03-31 | $829.14K 6-K · filed 2022-08-16 | |
| 2021-09-30 | $785.55K 20-F · filed 2023-02-10 | |
| 2020-09-30 | $186.54K 20-F · filed 2022-01-31 |